TICE® BCG - BCG LIVE (for Intravesical Use)
About Bladder CancerAbout TICE® BCGYou & TICEFAQs
 
Home >>

About Bladder Cancer

Right From the Beginning

Once you have received a diagnosis of non-muscle-invasive bladder cancer, the most important thing for you to know is that patients generally respond well to treatment. This is true for patients with bladder cancer in the form of papillary tumors (type Ta or T1) or CIS.

Your doctor has recommended that you be treated for your cancer with TICE® BCG, BCG LIVE (For Intravesical Use). You are fortunate because your bladder cancer was diagnosed early and is likely to respond to treatment. With appropriate therapy and attention to your doctor’s recommendations, the outlook for controlling your cancer is favorable.

This area of the website will help you understand your illness, the treatment with TICE® BCG that has been recommended for you, and the importance of following your doctor’s instructions to make your treatment as effective as possible.




TICE® BCG - BCG LIVE (for Intravesical Use) Home | Contact Us | Privacy | Terms of Use | Prescribing Info | Site Map
©2008 Organon USA Inc. All Rights Reserved